Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.                                 Description
  99.1          Protagonist Therapeutics, Inc. PN-943 Phase 2 Topline Data Press
              Release (April 25, 2022)
  99.2          PN-943 Phase 2 Topline Data Investor Presentation (April 25, 2022)
104            Cover Page Interactive Data File (embedded within the inline XBRL
              document)

The information in this report, including the exhibits hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Protagonist Therapeutics, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.

© Edgar Online, source Glimpses